Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus

Guglielmi S., Merz T. M., Gugger M., Suter C., Nicod L. P.

Source: Eur Respir J 2008; 31: 213-217
Journal Issue: January
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Guglielmi S., Merz T. M., Gugger M., Suter C., Nicod L. P.. Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus. Eur Respir J 2008; 31: 213-217

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Idiopathic interstitial pneumonia and connective tissue disorder-related interstitial lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=170
Year: 2007

Tacrolimus for antisynthetase syndrome with interstitial lung disease?
Source: Eur Respir J 2008; 32: 244-245
Year: 2008


Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
Source: Eur Respir J 2011; 38: 384-391
Year: 2011



Severe airflow obstruction and eosinophilic lung disease after Stevens-Johnson syndrome
Source: Eur Respir J 2006; 28: 1276-1279
Year: 2006



Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010


Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases.
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis
Source: Eur Respir J 2003; 22: 245-250
Year: 2003



Hypereosinophilic obliterative bronchiolitis: a distinct, unrecognised syndrome
Source: Eur Respir J 2013; 41: 1126-1134
Year: 2013



Hyaline membranes in pulmonary, extrapulmonary and idiopathic acute respiratory distress syndrome: non-homogeneous immunostaining
Source: Eur Respir J 2006; 28: Suppl. 50, 743s
Year: 2006

The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008



Idiopathic pulmonary haemosiderosis revisited
Source: Eur Respir J 2004; 24: 162-169
Year: 2004



Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009



Pulmonary involvement in antisynthetase syndrome: more than myopathy
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021


Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 18: 43S-55S
Year: 2001



Idiopathic pulmonary fibrosis (IPF) and idiopathic nonspecific interstitial pneumonia (NSIP): what treatment and for whom?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006


Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


Idiopathic eosinophilic pneumonias
Source: Eur Respir Mon 2011; 54: 118-139
Year: 2011


Clinical experience with nintedanib for the treatment of IPF in 80 cases
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Interstitial lung diseases in childhood
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=213
Year: 2002

Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
Source: Eur Respir J 2005; 25: 528-533
Year: 2005